Area of research
Biomaterials · Cellular and Molecular Neuroscience
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Nuclear Receptors and Signaling, Salivary Gland Tumors Diagnosis and Treatment, and RNA Interference and Gene Delivery.
Establishment and Characterization of a Novel Human Ocular Adnexal Sebaceous Carcinoma Cell Line
Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland
The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy
Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC)
Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer
Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer
Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer
Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer
Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma
Chemoprevention of Skin Cancer with 1,1-Bis (3′-Indolyl)-1-(Aromatic) Methane Analog through Induction of the Orphan Nuclear Receptor, NR4A2 (Nurr1)